SAB Biotherapeutics (SABS) Interest & Investment Income (2021 - 2025)
Historic Interest & Investment Income for SAB Biotherapeutics (SABS) over the last 5 years, with Q3 2025 value amounting to $655233.0.
- SAB Biotherapeutics' Interest & Investment Income rose 13639.77% to $655233.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $867667.0, marking a year-over-year decrease of 4688.85%. This contributed to the annual value of $1.3 million for FY2024, which is 11984.15% up from last year.
- Per SAB Biotherapeutics' latest filing, its Interest & Investment Income stood at $655233.0 for Q3 2025, which was up 13639.77% from $13562.0 recorded in Q2 2025.
- SAB Biotherapeutics' 5-year Interest & Investment Income high stood at $655233.0 for Q3 2025, and its period low was $3769.0 during Q3 2021.
- In the last 5 years, SAB Biotherapeutics' Interest & Investment Income had a median value of $28568.0 in 2023 and averaged $141918.1.
- As far as peak fluctuations go, SAB Biotherapeutics' Interest & Investment Income surged by 182964.36% in 2024, and later plummeted by 9637.92% in 2025.
- Over the past 5 years, SAB Biotherapeutics' Interest & Investment Income (Quarter) stood at $8544.0 in 2021, then soared by 250.29% to $29929.0 in 2022, then soared by 1517.31% to $484046.0 in 2023, then crashed by 71.83% to $136374.0 in 2024, then soared by 380.47% to $655233.0 in 2025.
- Its last three reported values are $655233.0 in Q3 2025, $13562.0 for Q2 2025, and $62498.0 during Q1 2025.